Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
427.6 INR | -2.92% | -4.70% | -0.34% |
05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
04-25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LAURUS LABS LIMITED | Other Pharmaceuticals | -2.70% | -4.70% | -0.34% | +29.24% | +490.81% | 2.85B |
Technical Rankings Surperformance
- Stock Market
- Equities
- LAURUSLABS Stock
- Charts Laurus Labs Limited
- Comparison Chart